Document:

EXHIBIT
      10.1

    

    DIRECTOR
      AGREEMENT

    

    This
      DIRECTOR AGREEMENT is made as of this 29 day of June, 2007 (the "Agreement"),
      by
      and between FuQi International, Inc., a Delaware corporation (the "Company")
      and
      [______] (the “Director”). 

    

    WHEREAS,
      the Company designs, develops, promotes and sells jewelry products in China
      (the
“Business”);

    

    WHEREAS,
      the Company wishes to appoint the Director as a non-executive member of the
      Board of Directors of the Company and enter into an agreement with the Director
      with respect to such appointment; and

    

    WHEREAS,
      the Director wishes to accept such appointment and to serve the Company on
      the
      terms set forth herein, and in accordance with, the provisions of this
      Agreement.

    

    NOW,
      THEREFORE, in consideration of the mutual covenants contained herein, the
      parties hereto agree as follows: 

    

    1. Position.
      Subject
      to the terms and provisions of this Agreement, the Company shall cause the
      Director to be appointed as non-executive member of the Board of Directors
      (the
“Board”) to fill an existing but now vacant directorship and the Director hereby
      agrees to serve the Company in that position upon the terms and conditions
      hereinafter set forth, provided however, that the Director's continued service
      on the Board after the initial term on the Board shall be subject to any
      necessary approval by the Company's stockholders.

    

    2. Duties.
      During
      the Directorship Term (as defined in Section 5 hereof), the Director shall
      serve
      as a member of the Board, and the Director shall make reasonable business
      efforts to attend all Board meetings, serve on appropriate subcommittees as
      reasonably requested by the Board, make himself available to the Company at
      mutually convenient times and places, attend external meetings and
      presentations, as appropriate and convenient, and perform such duties, services
      and responsibilities and have the authority commensurate to such
      position.

    

    The
      Director will use his best efforts to promote the interests of the Company.
      The
      Company recognizes that the Director (i) is a full-time executive employee
      of
      another entity and that his responsibilities to such entity must have priority
      and (ii) sits on the Board of Directors of other entities; although Director
      will use reasonable business efforts to coordinate his respective commitments
      so
      as to fulfill his obligations to the Company and, in any event, will fulfill
      his
      legal obligations as a director. Other than as set forth above, the Director
      will not, without the prior written approval of the Board, engage in any other
      business activity which could materially interfere with the performance of
      his
      duties, services and responsibilities hereunder or which is in violation of
      the
      reasonable policies established from time to time by the Company, provided
      that
      the foregoing shall in no way limit his activities on behalf of (i) his current
      employer and its affiliates or (ii) the Board of Directors of those entities
      on
      which he sits.

    

    3. Monetary
      Remuneration.

    

    (a)
      Fees
      and Compensation. During the Directorship Term the Director shall receive the
      following compensation and benefits: 

    

    
      	
            	—	
              An
                annual fee of U.S. $20,000

            

    

    
      	
            	—	
              A
                fee of U.S. $2,000 for each in-person meeting
                attended

            

    

    
      	
            	—	
              An
                annual fee of U.S. $2,500 for serving on the Company’s Audit
                Committee

            

    

    
      	
            	—	
              An
                annual fee of U.S. $2,000 for serving on the Company’s Compensation
                Committee

            

    

    

    The
      Director's status during the Agreement Term shall be that of an independent
      contractor and not, for any purpose, that of an employee or agent with authority
      to bind the Company in any respect. All payments and other consideration made
      or
      provided to the Director under Sections 3 and 4 shall be made or provided
      without withholding or deduction of any kind, and the Director shall assume
      sole
      responsibility for discharging, all tax or other obligations associated
      therewith.

    

    (b)
      Expense Reimbursements. During the Directorship Term, the Company shall
      reimburse the Director for all reasonable out-of-pocket expenses incurred by
      the
      Director in attending any in-person meetings, provided that the Director
      complies with the generally applicable policies, practices and procedures of
      the
      Company for submission of expense reports, receipts or similar documentation
      of
      such expenses. Any reimbursements for allocated expenses (as compared to
      out-of-pocket expenses of the Director) must be approved in advance by the
      Company.

    

    4. Equity
      Arrangements.
      Subject
      to the Board’s approval, the Company shall grant the Director, on the effective
      date of the Company’s proposed public offering (the “Offering”), under the
      Company’s 2006 Equity Incentive Plan, a non-qualified ten-year stock option (the
      "Option") to purchase 30,000 (Thirty Thousand) shares of common stock at an
      exercise price per share equal to 100% of the Offering price with a vesting
      schedule of one-half being vested upon the effective date of the Offering,
      the
      remaining one-half being vested in four equal quarterly installments thereafter,
      the vesting predicate on Director’s continued service on the Board of Directors
      at the date of vesting, and other terms pursuant to an option agreement
      substantially in the form of agreement entered into by the Company and its
      other
      Board members (the "Option Agreement"). The Board will also consider the grant
      of additional stock options each year after the first year that Director serves
      on the Board of Directors. 

    

    
      
         

      

      
         

        
          

        

      

      
         

      

       

    

    5. Directorship
      Term.
      The
      "Directorship Term", as used in this Agreement, shall mean the period commencing
      on the date hereof and terminating on the earliest of the following to
      occur:

    

    (a)
      the
      death of the Director ("Death");

    

    (b)
      the
      termination of the Director from the position of member of the
      Board;

     

    (c)
      the
      resignation by the Director from the Board if after the date hereof, the chief
      executive officer of his current employer determines that the Director's
      continued service on the Board conflicts with his fiduciary obligations to
      his
      current employer (a "Fiduciary Resignation") and;

    

    (d)
      the
      resignation by the Director from the Board if the board of directors or the
      chief executive officer of his current employer requires the Director to resign
      and such resignation is not a Fiduciary Resignation.

     

    6. Director's
      Representation and Acknowledgment.
      Based
      on the understanding that the Company is currently only engaged in the Business,
      the Director represents to the Company that his execution and performance of
      this Agreement shall not be in violation of any agreement or obligation (whether
      or not written) that he may have with or to any person or entity, including
      without limitation, any prior employer. The Director hereby acknowledges and
      agrees that this Agreement (and any other agreement or obligation referred
      to
      herein) shall be an obligation solely of the Company, and the Director shall
      have no recourse whatsoever against any stockholder of the Company or any of
      their respective affiliates with regard to this Agreement.

    

    7.
      Director
      Covenants.

    

    (a)
      Unauthorized Disclosure. The Director agrees and understands that in the
      Director's position with the Company, the Director has been and will be exposed
      to and receive information relating to the confidential affairs of the Company,
      including but not limited to technical information, business and marketing
      plans, strategies, customer information, other information concerning the
      Company's products, promotions, development, financing, expansion plans,
      business policies and practices, and other forms of information considered
      by
      the Company to be confidential and in the nature of trade secrets. The Director
      agrees that during the Directorship Term and thereafter, the Director will
      keep
      such information confidential and will not disclose such information, either
      directly or indirectly, to any third person or entity without the prior written
      consent of the Company; provided, however, that (i) the Director shall have
      no
      such obligation to the extent such information is or becomes publicly known
      or
      generally known in the Company's industry other than as a result of the
      Director's breach of his obligations hereunder and (ii) the Director may, after
      giving prior notice to the Company to the extent practicable under the
      circumstances, disclose such information to the extent required by applicable
      laws or governmental regulations or judicial or regulatory process. This
      confidentiality covenant has no temporal, geographical or territorial
      restriction. Upon termination of the Directorship Term, the Director will
      promptly return to the Company all property, keys, notes, memoranda, writings,
      lists, files, reports, customer lists, correspondence, tapes, disks, cards,
      surveys, maps, logs, machines, technical data or any other tangible product
      or
      document which has been produced by, received by or otherwise submitted to
      the
      Director in the course or otherwise as a result of the Director's position
      with
      the Company during or prior to the Directorship Term, provided that, the Company
      shall retain such materials and make them available to the Director if requested
      by him in connection with any litigation against the Director under
      circumstances in which (i) the Director demonstrates to the reasonable
      satisfaction of the Company that the materials are necessary to his defense
      in
      the litigation, and (ii) the confidentiality of the materials is preserved
      to
      the reasonable satisfaction of the Company.

    

    (b)
      Non-Solicitation. During the Noncompetition Term, the Director shall not
      interfere with the Company's relationship with, or endeavor to entice away
      from
      the Company, any person who, on the date of the termination of the Directorship
      Term, was an employee or customer of the Company or otherwise had a material
      business relationship with the Company.

    

    The
      provisions of this Section 7 shall survive any termination of the Directorship
      Term, and the existence of any claim or cause of action by the Director against
      the Company, whether predicated on this Agreement or otherwise, shall not
      constitute a defense to the enforcement by the Company of the covenants and
      agreements of this Section 7.

    

    8. Indemnification.
      The
      Company agrees to indemnify the Director for his activities as a director of
      the
      Company to the fullest extent permitted by law, and to cover the Director under
      any directors and officers liability insurance obtained by the Company. Further,
      the Company and the Director agree to enter into an indemnification agreement
      substantially in the form of agreement entered into by the Company and its
      other
      Board members.

    

    9. Non-Waiver
      of Rights.
      The
      failure to enforce at any time the provisions of this Agreement or to require
      at
      any time performance by the other party of any of the provisions hereof shall
      in
      no way be construed to be a waiver of such provisions or to affect either the
      validity of this Agreement or any part hereof, or the right of either party
      to
      enforce each and every provision in accordance with its terms. No waiver by
      either party hereto of any breach by the other party hereto of any provision
      of
      this Agreement to be performed by such other party shall be deemed a waiver
      of
      similar or dissimilar provisions at that time or at any prior or subsequent
      time.

    

    
      
         

      

      
         

        
          

        

      

      
         

      

       

    

    10. Notices.
      Every
      notice relating to this Agreement shall be in writing and shall be given by
      personal delivery or by registered or certified mail, postage prepaid, return
      receipt requested; to:

    

    If
      to the
      Company:

    

    FuQi
      International, Inc.

    5/F.,
      Block 1, Shi Hua Industrial Zone

    Cui
      Zhu
      Road North

    Shenzhen,
      518019

    People’s
      Republic of China

    

    with
      a
      copy to: 

    

    Kirkpatrick
      & Lockhart Preston Gates Ellis LLP

    10100
      Santa Monica Blvd., 7th
      Floor

    Los
      Angeles, California 90067

    Telephone:
      (310) 552-5000

    Attention:
      Thomas J. Poletti, Esq.

    

    If
      to the
      Director:

     

    ____________________________

    ____________________________

    ____________________________

    

    Either
      of
      the parties hereto may change their address for purposes of notice hereunder
      by
      giving notice in writing to such other party pursuant to this Section
      10.

    

    11. Binding
      Effect/Assignment.
      This
      Agreement shall inure to the benefit of and be binding upon the parties hereto
      and their respective heirs, executors, personal representatives, estates,
      successors (including, without limitation, by way of merger) and assigns.
      Notwithstanding the provisions of the immediately preceding sentence, neither
      the Director nor the Company shall assign all or any portion of this Agreement
      without the prior written consent of the other party.

    

    12. Entire
      Agreement.
      This
      Agreement (together with the other agreements referred to herein) sets forth
      the
      entire understanding of the parties hereto with respect to the subject matter
      hereof and supersedes all prior agreements, written or oral, between them as
      to
      such subject matter.

    

    13. Severability.
      If any
      provision of this Agreement, or any application thereof to any circumstances,
      is
      invalid, in whole or in part, such provision or application shall to that extent
      be severable and shall not affect other provisions or applications of this
      Agreement.

    

    14. Governing
      Law.
      This
      Agreement shall be governed by and construed in accordance with the internal
      laws of the State of Delaware, without reference to the principles of conflict
      of laws. All actions and proceedings arising out of or relating to this
      Agreement shall be heard and determined in any Delaware state or federal court
      and the parties hereto hereby consent to the jurisdiction of such courts in
      any
      such action or proceeding; provided, however, that neither party shall commence
      any such action or proceeding unless prior thereto the parties have in good
      faith attempted to resolve the claim, dispute or cause of action which is the
      subject of such action or proceeding through mediation by an independent third
      party.

    

    15. Legal
      Fees.
      The
      parties hereto agree that the non-prevailing party in any dispute, claim, action
      or proceeding between the parties hereto arising out of or relating to the
      terms
      and conditions of this Agreement or any provision thereof (a "Dispute"), shall
      reimburse the prevailing party for reasonable attorney's fees and expenses
      incurred by the prevailing party in connection with such Dispute; provided,
      however, that the Director shall only be required to reimburse the Company
      for
      its fees and expenses incurred in connection with a Dispute, if the Director's
      position in such Dispute was found by the court, arbitrator or other person
      or
      entity presiding over such Dispute to be frivolous or advanced not in good
      faith.

    

    16. Modifications.
      Neither
      this Agreement nor any provision hereof may be modified, altered, amended or
      waived except by an instrument in writing duly signed by the party to be
      charged.

    

    17. Tense
      and Headings.
      Whenever any words used herein are in the singular form, they shall be construed
      as though they were also used in the plural form in all cases where they would
      so apply. The headings contained herein are solely for the purposes of
      reference, are not part of this Agreement and shall not in any way affect the
      meaning or interpretation of this Agreement.

    

    
      
         

      

      
         

        
          

        

      

      
         

      

       

    

    18. Counterparts.
      This
      Agreement may be executed in two or more counterparts, each of which shall
      be
      deemed to be an original but all of which together shall constitute one and
      the
      same instrument.

    

    (remainder
      of this page intentionally left blank)

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    IN
      WITNESS WHEREOF, the Company has caused this Director Agreement to be executed
      by authority of its Board of Directors, and the Director has hereunto set his
      hand, on the day and year first above written. 

    

    FuQi
      International, Inc.

    

     

    By: 
      __________________________________

    Name:
      Yu
      Kwai
      Chong

    Title:
      Chairman
      & C.E.O

    

    

    

    DIRECTOR

    

     

    ______________________________________

    Name:Unassociated Document

    SEPARATION,
      RESTRICTIVE COVENANTS AND

    RELEASE
      AGREEMENT

    

    This
      SEPARATION, RESTRICTIVE COVENANTS AND RELEASE AGREEMENT (the “Agreement”) is
      made and entered into as of June 28, 2007, by and between infoUSA, Inc., a
      Delaware corporation (“infoUSA”), Guideline, Inc. a New York corporation
      (“Guideline”), and David Walke, an individual (“Walke”).

    

    BACKGROUND

    

    
      	 	
              A.

            	
              Guideline
                and Walke are parties to that certain employment agreement dated
                November
                21, 2001, as amended January 1, 2005 (the “Employment Agreement”),
                pursuant to which Walke is currently employed as the Chief Executive
                Officer of Guideline.

            

    

    

    
      	 	
              B.

            	
              Contemporaneously
                herewith, infoUSA and Guideline have entered into an Agreement and
                Plan of
                Merger (the “Merger Agreement”), pursuant to which a wholly-owned
                subsidiary of infoUSA (the “Subsidiary”) will conduct a tender offer for
                all of the outstanding shares of capital stock of Guideline, after
                which
                such subsidiary will be merged with and into Guideline (the “Merger”),
                with Guideline continuing as the surviving corporation (the “Surviving
                Corporation”).

            

    

    

    
      	 	
              C.

            	
              Contemporaneously
                herewith, infoUSA and Walke, in his capacity as a stockholder of
                Guideline, have entered into a Stockholder Support Agreement (the
“Support
                Agreement”), pursuant to which Walke has agreed to tender all shares of
                Guideline capital stock owned by him to the Subsidiary, to vote in
                favor
                of the Merger and against any competing proposal, and to take (or
                refrain
                from taking) various other actions to facilitate the consummation
                of the
                Merger.

            

    

    

    
      	 	
              D.

            	
              As
                a condition to entering into the Merger Agreement, infoUSA has requested
                that Guideline and Walke enter into this Agreement providing for
                the
                termination of Walke’s employment, the satisfaction of the obligations of
                Guideline pursuant to the Employment Agreement, and certain
                non-competition, non-interference, confidentiality and intellectual
                property related obligations on the part of Walke, and Guideline
                and Walke
                have agreed to do the same, subject to the closing of the tender
                offer
                contemplated by the Merger
                Agreement.

            

    

    

    AGREEMENT

    

    NOW
      THEREFORE, in consideration of the discharge of the obligations of Guideline
      pursuant to the Employment Agreement, the payment of the Termination Payment
      (as
      defined below) and the other promises contained in this Agreement, and for
      other
      good and valuable consideration, the receipt and sufficiency of which is hereby
      acknowledged, infoUSA, Guideline and Walke, intending to be legally bound,
      hereby agree as follows:

    

    1. Termination.
      Subject
      to the occurrence of, and effective as of, the receipt of the Termination
      Payment (as hereinafter defined), Walke’s employment with Guideline will
      terminate and all agreements between Walke and Guideline or any affiliate of
      Guideline relating to Walke’s employment or the terms and conditions thereof,
      including without limitation the Employment Agreement, shall be terminated
      and
      superseded by this Agreement. In the event the Merger Agreement is terminated,
      this Agreement shall be deemed terminated and shall be null and
      void.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    2. Employment. Walke's
      employment will continue through the date of receipt of the Termination Payment
      (the “Termination Date”), at which time Walke's employment with Guideline will
      terminate as set forth in Section 1 hereof. Walke will continue to receive
      his
      salary and benefits, at their current levels, up to and including the
      Termination Date. 

    

    3. Termination
      Payment.
      infoUSA, or Guideline at the direction of infoUSA and/or Subsidiary, shall
      pay
      to Walke a total sum of One Million Three Hundred Thousand Dollars
      ($1,300,000.00), payable in full via wire transfer (the “Termination Payment”).
      The Termination Payment shall be due and payable on the date that infoUSA and/or
      the Subsidiary accept tender of a total of at least sixty-six and two-thirds
      percent (66 2/3%) or more of the outstanding shares of capital stock of
      Guideline pursuant to the Merger Agreement (the “Closing”). Walke agrees and
      acknowledges that the Termination Payment constitutes full and adequate
      consideration for the obligations of Walke set forth herein (including without
      limitation the covenants set forth in Section 4) and is intended to include
      payment for, and fully, fairly and adequately discharge, any and all obligations
      of Guideline and its affiliates to Walke pursuant to the Employment Agreement
      and any and all benefits plans and programs in which Walke participates, except
      for any requirements imposed by applicable law. Guideline agrees to comply
      with
      all legal obligations to provide Walke and the Internal Revenue Service with
      notice of the receipt of the Termination Payment by Walke. Walke, and not
      infoUSA, Guideline or Subsidiary, will be responsible for all payments of taxes
      required as a result of his receipt of the Termination Payment, and agrees
      to
      indemnify, defend and hold harmless infoUSA, Guideline and Subsidiary and their
      affiliates and successors and assigns from and against any claim or liability
      arising out of any failure to timely pay any taxes alleged to be due with
      respect to the Termination Payment.

    

    4. Restrictive
      Covenants.
      Walke
      acknowledges that Guideline is in the information services business and that
      Walke, as Chief Executive Officer of Guideline, is familiar in detail with
      the
      activities of Guideline and has participated in formulating such activities;
      that he is familiar in detail with the activities and future plans of Guideline;
      and that his position has given him a thorough knowledge of Guideline’s
      customers, suppliers and servicing and marketing operations. Accordingly, in
      consideration of the receipt of the Termination Payment, Walke hereby agrees
      and
      covenants as follows:

    

    
      	 	
              a.

            	
              Noncompetition.
                For a period commencing on the Termination Date and for a period
                of three
                (3) years immediately thereafter (the “Covenant Period”), unless otherwise
                consented to by the Surviving Corporation or infoUSA in writing,
                Walke
                shall not: 

            

    

    

    
      	 	
              i.

            	
              within
                any city, town, county, state or country in which Guideline or any
                of its
                affiliates currently conducts or does business, as of the Termination
                Date
                or at any time during the one year period prior to the Termination
                Date,
                either for himself or as an equity owner, director, manager, officer,
                employee, independent contractor or representative, directly or indirectly
                render services to or solicit business on behalf of any other business
                or
                corporation, firm, partnership, association, trust, group, joint
                venture,
                or other entity or individual proprietorship that is engaged in any
                line
                of business that is competitive with any line of business in which
                Guideline or its affiliates were engaged (or in which they intended
                to
                engage, as evidenced by some writing (e.g., a plan, corporate minutes,
                memoranda or letter), expenditure or other indication of a genuine
                interest in the line of business)), as of the Termination Date or
                at any
                time during the one year period prior to the Termination Date (a
                “Competing Business”); or

            

    

    

    
      	 	
              ii.
                

            	
              acquire
                a direct or indirect interest or an option to acquire such interest
                in any
                Competing Business (other than an interest of not more than 5% of
                any
                class of the outstanding securities of any company which are publicly
                traded on a national stock exchange or the over-the-counter
                market).

            

    

     

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

     

    
      	 	
              b.

            	
              Noninterference.
                During the Covenant Period, unless otherwise consented to by the
                Surviving
                Corporation or infoUSA in writing, Walke shall
                not:

            

    

    

    
      	 	
              i.

            	
              encourage,
                in any way or for any reason, any supplier or customer or client
                of
                Guideline or any of its affiliates or any of their respective, successors
                or assigns to sever or alter the relationship of such supplier or
                customer
                or client with Guideline or such affiliate, successor or
                assign;

            

    

    

    
      	 	
              ii.

            	
              aid
                any other person attempting to take suppliers or customers or clients
                from
                Guideline or such affiliates, successors or
                assigns;

            

    

    

    
      	 	
              iii.

            	
              serve
                or work in any way for any customers or clients of Guideline or its
                affiliates, or their successors or assigns, who were such customers
                or
                clients as of the Termination Date or during the preceding one (1)
                year
                period that would be competitive with
                Guideline;

            

    

    

    
      	 	
              iv.

            	
              solicit,
                employ, retain as a consultant, interfere with or attempt to entice
                away
                from Guideline or its affiliates, successors or assigns any current
                employee thereof or any individual who has agreed to be, or has been,
                employed or retained by Guideline or an affiliate, or their successors
                or
                assigns, within one (1) year prior to such solicitation, employment,
                retention, interference or
                enticement.

            

    

    

    
      	 	
              c.

            	
              Nondisparagement.
                Walke shall not disparage or defame infoUSA, Guideline, the Surviving
                Corporation, or their respective affiliates, successors or assigns,
                or any
                director, officer or employee of any of the foregoing, or otherwise
                cause
                any negative publicity to be disseminated about such entities or
                persons
                or their products or services either orally or in writing. Without
                limiting the generality of the foregoing, Walke shall not, without
                the
                prior written consent of infoUSA or the Surviving Corporation, in
                any
                manner disclose, divulge or discuss any Confidential Information,
                as
                hereinafter defined; provided,
                however,
                that Walke shall be permitted to disclose the dates of his employment
                with
                Guideline and his position and responsibilities and to disclose any
                facts
                that infoUSA, Guideline, the Surviving Corporation or their respective
                affiliates, successors or assigns have previously publicly disclosed.
                Neither infoUSA, the Surviving Corporation or any affiliate, successor
                or
                assign of the foregoing shall disparage or defame Walke or otherwise
                cause
                any negative publicity to be disseminated about Walke either orally
                or in
                writing.

            

    

    

    
      	 	
              d.

            	
              Confidentiality.
                Walke shall not use, appropriate or disclose to any person, directly
                or
                indirectly, any “Confidential Information” of infoUSA, Guideline, the
                Surviving Corporation or their affiliates, successors or assigns
                during
                the Covenant Period. Upon the Termination Date, Walke shall immediately
                return to the Surviving Corporation, in good condition, all Confidential
                Information, including all copies of the same, as well as all documents,
                data and records of any kind and in any form (including computer
                records)
                which contain any Confidential Information of infoUSA, Guideline
                or their
                affiliates, or which were prepared based on such Confidential Information.
                “Confidential Information” means confidential and proprietary information
                of the specified entity that includes, but is not limited to, information
                about products, services, markets, customers, prospective customers,
                personnel, compensation, accounting, financial and technical data,
                business plans and operational and marketing strategies. “Confidential
                Information” shall not include any information that is (i) generally known
                to the industry or the public other than as a result of Walke’s breach of
                this covenant or any breach of other confidentiality obligations
                by Walke
                or third parties; or (ii) required by law or judicial process to
                be
                disclosed; provided
                that Walke shall give prompt written notice to infoUSA and Guideline
                of
                such requirement, disclose no more information that is so required,
                and
                cooperative with any attempts by infoUSA or Guideline to obtain a
                protective order or similar
                treatment.

            

    

     

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

     

    
      	 	
              e.

            	
              Intellectual
                Property.
                Walke shall not, directly or indirectly, use, appropriate or interfere
                with any “Intellectual Property” (as defined below), of Guideline or its
                affiliates, or any combination, abbreviation or derivation thereof,
                or any
                applicable logos of such entities. Walke covenants and agrees that
                he:
                

            

    

    

    
      	 	
              i.

            	
              has
                disclosed to Guideline, and that Guideline owns, all right, title
                and
                interest in, all inventions, improvements, technical information,
                methods,
                computer software and other intellectual property (the “Walke Developed
                Intellectual Property”) which Walke conceived or developed during the
                course of his employment (excluding that which Walke conceived or
                developed without the use of time, resources or facilities of Guideline
                and which does not relate to the past, present or prospective activities
                of Guideline);

            

    

    

    
      	 	
              ii.

            	
              will,
                at the request of Guideline or the Surviving Corporation, affix
                appropriate legends and copyright notices indicating Guideline’s or the
                Surviving Corporation’s ownership of all Walke Developed Intellectual
                Property and all underlying documentation; and

            

    

    

    
      	 	
              iii.

            	
              will
                execute such further assignments and other documents as may be reasonably
                requested by Guideline or the Surviving Corporation in order to vest,
                perfect, maintain or defend Guideline’s or the Surviving Corporation’s
                right, title and interest in the Walke Developed Intellectual
                Property.

            

    

    

    
      	 	
              iv.

            	
              “Intellectual
                Property” means: (a) all inventions (whether patentable or unpatentable
                and whether or not reduced to practice), all improvements thereto,
                and all
                patents, patent applications and patent disclosures, together with
                all
                reissuances, continuations, continuations-in-part, revisions, extensions
                and reexaminations thereof; (b) all trademarks, service marks, trade
                dress, logos, trade names, corporate names and domain names, together
                with
                all abbreviations, translations, adaptations, derivations and combinations
                thereof and including all goodwill associated therewith, and all
                applications, registrations and renewals in connection therewith;
                (c) all
                copyrightable works, all copyrights and all applications, registrations
                and renewals in connection therewith; (d) all mask works and all
                applications, registrations and renewals in connection therewith;
                (e) all
                trade secrets and confidential business information (including ideas,
                research and development, know-how, formulas, compositions, manufacturing
                and production processes and techniques, technical data, designs,
                drawings, specifications, customer and supplier lists, pricing and
                cost
                information and business and marketing plans and proposals); (f)
                all
                computer software (including data and related documentation); (g)
                all
                other proprietary rights; and (h) all copies and tangible embodiments
                thereof (in whatever form or
                medium).

            

    

    

    5. Return
      of Guideline Property.
      Upon
      termination of Walke’s employment, Walke shall immediately return to Guideline
      or the Surviving Corporation all Guideline property including, without
      limitation, Guideline credit cards, Guideline keys, and Guideline calling
      cards.

     

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

    

    6. No
      Admission.
      The
      parties agree that neither this Agreement nor any obligations under this
      Agreement constitute an admission by infoUSA, Guideline, the Surviving
      Corporation or Walke of any violation of any federal, state or local laws,
      rules, regulations or ordinances, or of any liability under contract or tort
      theories, of any nature whatsoever.

    

    7. Release.
      Subject
      to the payment in full of the Termination Payment, and effective as of the
      Termination Date, Walke, on behalf of himself and his agents, family members,
      heirs, successors and assigns, hereby releases infoUSA, Guideline, the Surviving
      Corporation, and the affiliates of each of the foregoing, and their respective
      shareholders, directors, officers, employees, and partners (or persons or
      entities of a comparable status (e.g., members and partners) or holding
      comparable positions (e.g., governors and managers)) and the successors and
      assigns of each of the foregoing (the “Released Parties”) from all claims and
      liabilities of any kind (including attorney’s fees) (“Claims”) that could have
      been asserted prior to, or based on facts or circumstances existing as of,
      the
      Termination Date, whether vested or contingent, known or unknown. Claims
      include, but are not limit to, any Claim alleging breach of contract, express
      or
      implied, promissory estoppel or any tort, and Claims under any federal, state
      statute or local ordinance, or government regulation or common laws, including,
      but not limited to, the Age Discrimination in Employment Act, Title VII of
      the
      Civil Rights Act of 1964, the Americans With Disabilities Act, the Fair Labor
      Standards Act, Family and Medical Leave Act, Employee Retirement Income Security
      Act, the New York Fair Employment Practices Act and the New York Wage Payment
      and Collection Act, all as amended. Guideline, infoUSA and the Surviving
      Corporation, and the affiliates of each of the foregoing, specifically
      acknowledge and agree that nothing contained herein shall be deemed to release
      Guideline, infoUSA, the Subsidiary and the Surviving Corporation from: (i)
      the
      breach of this Agreement; (ii) any statutory claims for state unemployment
      insurance, workers compensation and disability insurance benefits; (iii) legal
      claims regarding non-bonus or non-incentive compensation related to payment
      of
      wages earned; (iv) and any legal obligations by either Guideline, infoUSA,
      the
      Subsidiary and the Surviving Corporation to indemnify Walke. 

    

    Walke
      acknowledges that certain states provide that a general release of claims does
      not extend to claims that the person/entity executing the release does not
      know
      or suspect to exist in her/its favor at the time of executing the release that,
      if known, may have materially affected the decision to enter into the release.
      Being aware that such statutory protection may be available, Walke expressly,
      voluntarily and knowingly waives any arguable benefit or protection of any
      such
      statute in executing this Agreement, whether such benefit or protection is
      known
      or unknown.

    

    Guideline
      represents and warrants to Walke that, to its knowledge (but excluding Walke’s
      knowledge), and infoUSA represents and warrants to Walke that, to its knowledge
      and based solely on information provided to it by Guideline, as of the date
      of
      this Agreement, they are not aware of any claims for actions arising from or
      related to Walke’s employment relationship with Guideline.

    

    8. Review
      Acknowledgment and Effective Date.
      By
      voluntarily executing this Agreement, Walke confirms and acknowledges that
      Walke
      has been advised to consult with and has consulted with an attorney, that Walke
      has read and understands this Agreement, that Walke has signed this Agreement
      freely and voluntarily. Walke further acknowledges that Walke has been given
      up
      to twenty-one (21) calendar days to consider signing this Agreement and Walke
      agrees that the changes, whether material or immaterial, made through
      negotiation with Walke’s legal counsel did not restart the running of the 21-day
      period. Walke may sign this Agreement at any time prior to the termination
      of
      the 21-day period. Additionally, Walke will have seven (7) calendar days
      following signing of this Agreement to rescind it and to reinstate federal
      age
      discrimination claims that he may have against Guideline. Such rescission must
      be in writing and received by infoUSA (attention: Fred Vakili) prior the end
      of
      the rescission period and accompanied by repayment to Guideline of all amounts
      that were previously paid to him pursuant to Section 2 of this Agreement,
      if any.

     

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

    

    9. Remedies.
      

    

    
      	 	
              a.

            	
              Walke
                acknowledges that each of infoUSA and the Surviving Corporation have
                relied on this Agreement and the covenants of Walke set forth herein
                in
                entering into the Merger Agreement and consummating the Merger, and
                therefore agrees that each of infoUSA and the Surviving Corporation
                are
                intended beneficiaries of this Agreement and that either or both
                of them
                will be entitled to the benefit of, and to enforce, the covenants
                of Walke
                set forth herein. infoUSA and/or the Surviving Corporation will have
                the
                right to injunctive relief, without the posting of any bond, to enforce
                the covenants set forth in this Agreement (including without limitation
                the restrictive provisions of Section 4) in addition to any other
                relief
                to which infoUSA and/or the Surviving Corporation may be entitled
                under
                law or in equity. Walke further agree that, if Walke violates any
                of the
                terms of this Agreement, including, but not limited to Section 4, or
                breaches any provision of the Support Agreement, infoUSA, Guideline
                and
                the Surviving Corporation will have no further obligations hereunder
                (including the payment obligation set forth in Section 2, if not
                yet
                performed), and infoUSA, Guideline or the Surviving Corporation will
                have
                the right to bring a legal action to recover damages resulting from
                Walke’s violation of this
                Agreement.

            

    

    

    
      	 	
              b.

            	
              infoUSA,
                the Subsidiary and the Surviving Corporation agree that the damages
                that
                would be suffered by Walke in the event that the Termination Payment
                is
                not paid in accordance with Section 3 hereof, would be extremely
                difficult
                and impracticable to ascertain. Accordingly, the parties agree that
                so
                long as Walke is not in material breach of this Agreement (and has
                not
                engaged in any conduct that would constitute a breach of this Agreement
                following payment of the Termination Payment) or his Employment Agreement,
                if infoUSA, the Subsidiary and the Surviving Corporation have not
                made the
                Termination Payment within seven (7) Business Days of the Closing,
                infoUSA, the Subsidiary and the Surviving Corporation shall be jointly
                and
                severally liable to pay to Walke the sum of Ten Thousand Dollars
                ($10,000)
                for each Business Day that the Termination Payment is late, commencing
                on
                the eighth (8th) Business Day after the Closing (the “Liquidated Damages
                Payment”); provided,
                however,
                that the seven (7) Business Day period for making the Termination
                Payment
                without imposition of the Liquidated Damages Payment will be tolled
                for a
                number of Business Days equal to the pendency of (a) any general
                banking
                moratorium or general suspension of payments in respect of banks
                or any
                limitation (whether or not mandatory) on the extension of credit
                by banks
                or other lending institutions in the United States; (b) any general
                suspension of, or limitation on, trading in securities on any national
                securities exchange or in the over-the-counter markets in the United
                States (or than any suspension or limitation on trading in any particular
                security as a result of a computerized trading limit or any intraday
                suspension due to “circuit breakers”); or (c) any other event or condition
                beyond the reasonable control of infoUSA that prohibits the making
                of the
                Termination Payment by infoUSA. For purposes of this Agreement, the
                term
                “Business Day” shall mean any day other than a day on which banks in the
                State of New York are required or authorized to be closed. infoUSA,
                the
                Subsidiary and the Surviving Corporation agree that the Liquidated
                Damages
                Payment represents the reasonable estimate by the parties of the
                amount of
                the damages that Walke would suffer by reason of the failure to pay
                the
                Termination Payment in accordance with Section 3 hereof, and that
                the
                Liquidated Damages Payment is a reasonable liquidated damage amount
                under
                the existing circumstances. Accordingly, in the event that the Termination
                Payment is not paid in accordance with Section 3 hereof, and provided
                that
                all of Walke’s obligations have been satisfied, Walke shall be entitled to
                receive and retain the Liquidated Damages Payment as liquidated damages,
                and not as a penalty.

            

    

     

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

    

     

    
      	 	
              c.

            	
              In
                the event of any action arising out of or relating to this Agreement
                or
                the enforcement thereof, the prevailing party will be entitled to
                recover,
                in addition to any damages awarded to such party, all costs and fees
                incurred in contemplation of and in connection with such action,
                including
                without limitation attorneys’ fees.

            

    

    

    10. General.

    

    
      	 	
              a.

            	
              Governing
                Law.
                This Agreement shall be governed by and construed and enforced in
                accordance with the laws of the State of New
                York.

            

    

    

    
      	 	
              b.

            	
              Entire
                Agreement.
                This Agreement sets forth the entire agreement and understanding
                of the
                parties relating to the subject matter hereof, and supersedes all
                prior
                agreements, arrangements and understandings, written or oral between
                the
                parties. Walke acknowledges that he has not relied on any representation
                or statement not set forth in this Agreement by any representative
                of the
                other parties hereto.

            

    

    

    
      	 	
              c.

            	
              Amendments
                and Assignment. Any
                amendment to, modification of, or supplement to this Agreement must
                be in
                writing and signed by infoUSA, Guideline and Walke. This Agreement
                shall
                not be assignable or delegable by Walke. This Agreement may be assigned
                by
                infoUSA or Guideline to any person or entity which is an affiliate
                and
                shall be assignable to any successor in interest to any part of the
                business of infoUSA or Guideline.

            

    

    

    
      	 	
              d.

            	
              Severability.
                If
                any of the covenants, agreements or restrictions contained in this
                Agreement shall be determined by a court of competent jurisdiction
                to be
                invalid or unenforceable, the same shall not affect the remainder
                of the
                covenants, agreements, restrictions, rights or remedies, which shall
                be
                given full effect without regard to the invalid or unenforceable
                portions,
                it being understood and agreed that all such covenants, agreements,
                restrictions, rights and remedies shall be deemed separate and severable.
                Additionally, and without limiting the foregoing, the parties hereto
                agree
                that if, at the time of enforcement of this Agreement, a court of
                competent jurisdiction shall hold that the duration, scope or area
                of the
                restrictions stated herein, including but not limited to any of the
                restrictive covenants set forth in Section 4 (inclusive), are unreasonable
                under the circumstances then existing, the maximum restrictions reasonable
                under such circumstances as then exist shall be substituted for the
                restrictions stated herein. 

            

    

    

    
      	 	
              e.

            	
              Counterparts/Electronic
                Transmission.
                This Agreement may be executed in one or more counterparts, any of
                which
                may be executed and transmitted by facsimile or other electronic
                method,
                and each of which shall be deemed an original, but all of which together
                shall constitute one and the same
                instrument.

            

    

    

    
      	 	
              f.

            	
              Further
                Assurances.
                The parties agree to promptly execute and deliver to each other any
                and
                all other documents and writings, in form approved by their respective
                counsel, that are necessary or appropriate for the full and efficient
                implementation of this agreement.

            

    

    

    
      	 	
              g.

            	
              Successors.
                This agreement shall inure to the benefit of and be enforceable by
                and
                binding upon infoUSA, the Subsidiary, Guideline and the Surviving
                Corporation, as well as their successors and assigns. This agreement
                shall
                inure to the benefit of and be enforceable by and binding upon Walke
                and
                his legal representatives.

            

    

    

    
      
        
        

      

      
        7

        
          

        

      

      
        
        

      

    

    

    IN
      WITNESS WHEREOF, the parties hereto have executed this Separation, Restrictive
      Covenants and Release Agreement as of the day and year first above
      written.

     

    
      	 	 	 
	 	
              infoUSA,
                Inc.

            
	 
 	 
/s/
              Fred
              Vakili
              

            
	 	By: 	 Fred Vakili
	
            	 Its:
	 Chief Administrative Officer 
	 	
            

    

     

    
      
        	 	 	 
	 	Guideline, Inc.
	 
 	
                
/s/ Peter
                  Stone 

                  

                

              
	 	By: 	 Peter Stone
	
              	 Its:
	 Chief Financial Officer and Secretary
	 	
              

      

      
         

        
          
            	 	 	 
	 	
                    Walke:

                  
	 
 	 
/s/
                    David Walke 

                    
David
                    Walke

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00125-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00125-of-00352.parquet"}]]